Comparison of Clinical Outcomes Using “Elevate Anterior” versus “Perigee” System Devices for the Treatment of Pelvic Organ Prolapse

Table 4

Urodynamic changes in both groups before and 6 months after surgery. Data are given as (%) or mean ± standard deviation.

Parameters	Perigee ( = 91)			Elevate ( = 50)
	Pre-op	Post-op	value	Pre-op	Post-op	value
DO	31 (34.1)	12 (13.2)	0.002	17 (34.0)	11 (22.0)	0.29
Qmax (mL/s)	18.6 ± 9.0	19.6 ± 10.2	0.26	21.0 ± 14.3	18.0 ± 8.9	0.06
RU (mL)	63.1 ± 45.3	32.8 ± 32.7	0.015	71.3 ± 50.3	36.6 ± 22.6	0.038
FS (mL)	164.6 ± 73.9	154.5 ± 64.3	0.23	135.7 ± 54.9	133.0 ± 59.5	0.79
MCC (mL)	409.5 ± 127.0	400.7 ± 111.4	0.35	332.5 ± 81.1	324.8 ± 109.4	0.57
Pdet (cmH2O)	26.5 ± 19.9	28.0 ± 17.9	0.52	19.5 ± 7.6	18.6 ± 11.0	0.68
FUL (mm)	24.6 ± 6.1	27.1 ± 4.9	0.07	27.8 ± 7.1	25.4 ± 8.4	0.14
MUCP (cmH2O)	56.3 ± 26.2	63.1 ± 34.2	0.25	73.0 ± 29.5	72.5 ± 24.9	0.90
UCA (mmcmH2O)	730.3 ± 456.9	816.5 ± 408.3	0.12	1012.6 ± 396.8	934.4 ± 391.8	0.11

DO, detrusor overactivity; Qmax, maximum flow rate; RU, residual urine; FS, first sensation to void; MCC, maximum cystometric capacity; Pdet, detrusor pressure at peak flow; FUL, functional urethral length; MUCP, maximum urethral closure pressure; UCA, urethral closure area.
McNemar’s test; Paired -test.
^∧Statistical significance.